ZNF582

gene
On this page

Also known as FLJ30927

Summary

ZNF582 (zinc finger protein 582, HGNC:26421) is a protein-coding gene on chromosome 19q13.43, encoding Zinc finger protein 582 (Q96NG8). May be involved in transcriptional regulation.

The protein encoded by this gene is a zing finger protein and putative transcription factor that is highly methylated in cervical cancers. Two transcript variants encoding different isoforms have been found for this gene.

Source: NCBI Gene 147948 — RefSeq curated summary.

At a glance

  • GWAS associations: 1
  • Clinical variants (ClinVar): 31 total
  • MANE Select transcript: NM_001320371

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:26421
Approved symbolZNF582
Namezinc finger protein 582
Location19q13.43
Locus typegene with protein product
StatusApproved
AliasesFLJ30927
Ensembl geneENSG00000018869
Ensembl biotypeprotein_coding
OMIM615600
Entrez147948

Gene structure

Transcript identifiers

Ensembl transcripts: 7 — 5 protein_coding, 2 non_stop_decay

ENST00000301310, ENST00000586929, ENST00000587778, ENST00000589143, ENST00000589895, ENST00000593145, ENST00000932869

RefSeq mRNA: 2 — MANE Select: NM_001320371 NM_001320371, NM_144690

CCDS: CCDS33121

Canonical transcript exons

ENST00000586929 — 5 exons

ExonStartEnd
ENSE000017085095639174456391832
ENSE000024809435639037556390501
ENSE000024933135639000156390096
ENSE000027807265638275156385184
ENSE000028651285639322056393534

Expression profiles

Bgee: expression breadth ubiquitous, 181 present calls, max score 88.07.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 2.8214 / max 54.2742, expressed in 1290 samples.

FANTOM5 promoters (2 alternative TSS)

Promoter IDTPM avgSamples expressed
1828791.84941037
1828800.9721548

Top tissues by expression

236 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
tibialis anteriorUBERON:000138588.07silver quality
primordial germ cell in gonadCL:0000670 ∩ UBERON:000099185.74gold quality
ileal mucosaUBERON:000033185.68gold quality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047384.96gold quality
upper arm skinUBERON:000426380.45gold quality
pancreatic ductal cellCL:000207979.92silver quality
apex of heartUBERON:000209879.00gold quality
right adrenal glandUBERON:000123378.06gold quality
C1 segment of cervical spinal cordUBERON:000646977.75gold quality
cerebellar hemisphereUBERON:000224577.63gold quality
cerebellar cortexUBERON:000212977.59gold quality
right adrenal gland cortexUBERON:003582777.58gold quality
right lobe of thyroid glandUBERON:000111977.52gold quality
left lobe of thyroid glandUBERON:000112077.43gold quality
adenohypophysisUBERON:000219677.26gold quality
epithelial cell of pancreasCL:000008377.20gold quality
right hemisphere of cerebellumUBERON:001489077.09gold quality
deltoidUBERON:000147676.91silver quality
left adrenal glandUBERON:000123476.78gold quality
spinal cordUBERON:000224076.71gold quality
left adrenal gland cortexUBERON:003582576.68gold quality
pituitary glandUBERON:000000776.64gold quality
islet of LangerhansUBERON:000000676.61gold quality
thyroid glandUBERON:000204676.55gold quality
cerebellumUBERON:000203776.46gold quality
putamenUBERON:000187476.43gold quality
nucleus accumbensUBERON:000188276.20gold quality
adrenal cortexUBERON:000123576.13gold quality
oocyteCL:000002375.96gold quality
caudate nucleusUBERON:000187375.87gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 0.

ExperimentMarker?Max mean expression
E-ANND-3no1.94

Regulation

Is transcription factor: yes

JASPAR motifs

MotifNameFamily
MA1983.1ZNF582More than 3 adjacent zinc fingers
MA1983.2ZNF582More than 3 adjacent zinc fingers

JASPAR matrix evidence (PMIDs): PMID:31162603

miRNA regulators (miRDB)

72 targeting ZNF582, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-4510100.0066.602050
HSA-MIR-6127100.0066.762188
HSA-MIR-6129100.0066.462080
HSA-MIR-6130100.0066.692012
HSA-MIR-6133100.0066.482064
HSA-MIR-3163100.0077.238605
HSA-MIR-428299.9975.366408
HSA-MIR-391099.9571.132227
HSA-MIR-1-3P99.9372.351914
HSA-MIR-20699.9372.501893
HSA-MIR-519E-5P99.9269.622358
HSA-MIR-515-5P99.9269.822343
HSA-MIR-6809-3P99.9171.453814
HSA-MIR-10527-5P99.9172.283754
HSA-MIR-61399.9171.501710
HSA-MIR-4753-3P99.9071.033786
HSA-MIR-548E-5P99.8972.734486
HSA-MIR-4671-3P99.8872.461045
HSA-MIR-605-3P99.8869.221833
HSA-MIR-548AR-3P99.8571.263889
HSA-MIR-629-3P99.8567.991875
HSA-MIR-684499.8270.692423
HSA-MIR-548AZ-3P99.8270.563549
HSA-MIR-548BC99.8270.613524
HSA-MIR-548E-3P99.8270.593514
HSA-MIR-548F-3P99.8270.593540
HSA-MIR-4760-5P99.8069.881619
HSA-MIR-129999.7771.242389
HSA-MIR-548A-3P99.7670.583524
HSA-MIR-4677-5P99.7070.091940

Literature-anchored findings (GeneRIF, showing 16)

  • ZNF582 is frequently methylated in cervical intraepithelial neoplasia 3 and worse lesions (PMID:22815913)
  • Methylation levels of ZNF582 in uterine cervix adenocarcinomas is significantly higher than those in normal cervical tissues. (PMID:24407576)
  • This is the first study to show that ZNF582 methylation analysis of cervical swabs may be a promising choice in the positive triage of cytological diagnoses of low-grade squamous intraepithelial lesions (PMID:25134998)
  • Results show that promoter hypermethylation of ADCY8, CDH8, and ZNF582 are correlated with high-grade squamous intraepithelial lesion. (PMID:27651839)
  • conclude that hypermethylated ZNF582 and PAX1 are effective biomarkers for the detection of oral dysplasia and oral cancer and for the prediction of oral cancer recurrence (PMID:27865370)
  • DNA methylation status of ZNF582 showed a relatively good sensitivity and specificity for the detection of ESOPHAGEAL SQUAMOUS CELL CARCINOMA. (PMID:28241446)
  • Hypermethylated ZNF582 and PAX1 genes in oral epithelial cells collected by mouth rinse are effective biomarkers for the detection of oral dysplasia and oral cancer. (PMID:28960639)
  • Hypermethylated ZNF582 and PAX1 genes in the oral scrapings collected from adjacent normal oral mucosal sites rather than cancer sites are associated with aggressive progression and poor prognosis of OSCC (PMID:29224816)
  • ZNF582 methylation has a prospect to be an auxiliary biomarker for cervical cancer (Meta-Analysis) (PMID:30732145)
  • The methylation levels ofPAX1, SOX1 and ZNF582 genes were all higher in cancer tissues. (PMID:31629253)
  • Hypermethylated PAX1 and ZNF582 genes in the tissue sample are associated with aggressive progression of oral squamous cell carcinoma. (PMID:32428271)
  • The application value of PAX1 and ZNF582 gene methylation in high grade intraepithelial lesion and cervical cancer. (PMID:32514824)
  • ZNF582 hypermethylation promotes metastasis of nasopharyngeal carcinoma by regulating the transcription of adhesion molecules Nectin-3 and NRXN3. (PMID:33038291)
  • ZNF582 promoter methylation predicts cervical cancer radiosensitivity and ZNF582 protein overexpression reduces radiosensitivity by cell cycle arrest in S phase. (PMID:35642528)
  • ZNF582 overexpression restrains the progression of clear cell renal cell carcinoma by enhancing the binding of TJP2 and ERK2 and inhibiting ERK2 phosphorylation. (PMID:36966163)
  • Relationship between p16/ki67 immunoscores and PAX1/ZNF582 methylation status in precancerous and cancerous cervical lesions in high-risk HPV-positive women. (PMID:39304838)

Cross-species orthologs

4 orthologs

OrganismSymbolGene ID
mus_musculusZfp582ENSMUSG00000109398
drosophila_melanogasterCG2712FBGN0024975
drosophila_melanogasterPhsFBGN0036522
drosophila_melanogasterCG3281FBGN0260741

Paralogs (62): ZNF264 (ENSG00000083844), ZNF343 (ENSG00000088876), ZNF684 (ENSG00000117010), ZNF133 (ENSG00000125846), ZNF557 (ENSG00000130544), ZNF337 (ENSG00000130684), ZNF20 (ENSG00000132010), ZFP37 (ENSG00000136866), ZNF614 (ENSG00000142556), KRBOX4 (ENSG00000147121), ZNF599 (ENSG00000153896), ZNF19 (ENSG00000157429), ZNF589 (ENSG00000164048), PRDM9 (ENSG00000164256), ZNF180 (ENSG00000167384), ZNF558 (ENSG00000167785), ZNF35 (ENSG00000169981), ZNF778 (ENSG00000170100), ZNF439 (ENSG00000171291), ZNF440 (ENSG00000171295), ZNF556 (ENSG00000172000), ZNF554 (ENSG00000172006), ZNF596 (ENSG00000172748), ZNF80 (ENSG00000174255), ZNF266 (ENSG00000174652), ZNF25 (ENSG00000175395), ZNF77 (ENSG00000175691), ZNF169 (ENSG00000175787), ZNF404 (ENSG00000176222), ZNF491 (ENSG00000177599), ZNF620 (ENSG00000177842), ZNF619 (ENSG00000177873), ZNF875 (ENSG00000181666), ZNF329 (ENSG00000181894), ZFP90 (ENSG00000184939), ZNF566 (ENSG00000186017), ZNF529 (ENSG00000186020), ZNF749 (ENSG00000186230), ZNF555 (ENSG00000186300), ZNF70 (ENSG00000187792)

Protein

Protein identifiers

Zinc finger protein 582Q96NG8 (reviewed: Q96NG8)

All UniProt accessions (5): A0A075B771, A0A075B772, Q96NG8, K7EKI7, K7ESE7

UniProt curated annotations — full annotation on UniProt →

Function. May be involved in transcriptional regulation.

Subcellular location. Nucleus.

Similarity. Belongs to the krueppel C2H2-type zinc-finger protein family.

RefSeq proteins (2): NP_001307300, NP_653291 (=MANE)

Domains & families (InterPro)

IDNameType
IPR001909KRABDomain
IPR013087Znf_C2H2_typeDomain
IPR036051KRAB_dom_sfHomologous_superfamily
IPR036236Znf_C2H2_sfHomologous_superfamily

Pfam: PF00096, PF01352

UniProt features (21 total): zinc finger region 10, sequence conflict 6, sequence variant 3, chain 1, domain 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q96NG8-F163.040.05

Function

Pathways and Gene Ontology

Reactome pathways

1 pathways

IDPathway
R-HSA-212436Generic Transcription Pathway

MSigDB gene sets: 44 (showing top): TCF11_01, NOUZOVA_METHYLATED_IN_APL, STAT1_02, YKACATTT_UNKNOWN, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, STAT1_03, FIGUEROA_AML_METHYLATION_CLUSTER_1_UP, FIGUEROA_AML_METHYLATION_CLUSTER_2_UP, FIGUEROA_AML_METHYLATION_CLUSTER_3_UP, FIGUEROA_AML_METHYLATION_CLUSTER_4_UP, FIGUEROA_AML_METHYLATION_CLUSTER_6_UP, FIGUEROA_AML_METHYLATION_CLUSTER_7_UP, GOMF_TRANSCRIPTION_REGULATOR_ACTIVITY, IRF5_TARGET_GENES, SUPT16H_TARGET_GENES

GO Biological Process (2): regulation of transcription by RNA polymerase II (GO:0006357), regulation of DNA-templated transcription (GO:0006355)

GO Molecular Function (6): RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977), DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), zinc ion binding (GO:0008270), DNA binding (GO:0003677), protein binding (GO:0005515), metal ion binding (GO:0046872)

GO Cellular Component (1): nucleus (GO:0005634)

Reactome top-level categories

Rollup of top-1 pathways:

CategoryPathways
RNA Polymerase II Transcription1

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
regulation of DNA-templated transcription1
transcription by RNA polymerase II1
DNA-templated transcription1
regulation of gene expression1
regulation of RNA biosynthetic process1
transcription cis-regulatory region binding1
chromatin1
RNA polymerase II transcription regulatory region sequence-specific DNA binding1
DNA-binding transcription factor activity1
regulation of transcription by RNA polymerase II1
transition metal ion binding1
nucleic acid binding1
binding1
cation binding1
intracellular membrane-bounded organelle1

Protein interactions and networks

STRING

348 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
ZNF582PAX1P15863776
ZNF582TAFA4Q96LR4579
ZNF582SOX1O00570577
ZNF582WDR17Q8IZU2542
ZNF582PTPRRQ15256479
ZNF582RUBCNLQ9H714479
ZNF582LHX8Q68G74474
ZNF582EPB41L3Q9Y2J2474
ZNF582ST6GALNAC5Q9BVH7418
ZNF582POU4F3Q15319403
ZNF582LMX1AQ8TE12382
ZNF582PCDHA13Q9Y5I0373
ZNF582CDH8P55286371
ZNF582PCDHA4Q9UN74364
ZNF582NKX6-1P78426353

IntAct

4 interactions, top by confidence:

ABTypeScore
ZNF582NECTIN4psi-mi:“MI:0915”(physical association)0.590
ZNF582ECE1psi-mi:“MI:0915”(physical association)0.370

BioGRID (6): PVRL4 (Affinity Capture-MS), PVRL4 (Affinity Capture-MS), ZNF582 (Proximity Label-MS), ZNF582 (Affinity Capture-MS), PVRL4 (Affinity Capture-MS), ZNF582 (Affinity Capture-MS)

ESM2 similar proteins: A0A1W2PQL4, A0JPL0, A2RRD8, A6NHJ4, A6NP11, B4DX44, O75346, O95780, P0CB33, P21506, P51508, P52738, Q0D2J5, Q0VGE8, Q12901, Q13360, Q14593, Q15973, Q2M218, Q2M3X9, Q2VY69, Q3SXZ3, Q5HY98, Q5RCJ2, Q5VIY5, Q6J6I6, Q7L2R6, Q86XU0, Q86Y25, Q8IW36, Q8IYN0, Q8IYX0, Q8N782, Q8N883, Q8N9Z0, Q8NDP4, Q95K49, Q969W8, Q96H40, Q96N58

Diamond homologs: A0A1W2PQL4, A6NK75, A6NN14, A6NNF4, A6NP11, A8MQ14, A8MTY0, A8MUV8, A8MXY4, B4DX44, B4DXR9, E9PYI1, O14628, O43345, O75290, O75346, O75373, O75437, O95780, P0CB33, P0DKX0, P0DPD5, P16373, P17019, P17038, P21506, P35789, P52736, P52738, P52744, Q03923, Q03924, Q03936, Q03938, Q05481, Q14586, Q14593, Q14929, Q15928, Q3KNS6

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

31 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance23
Likely benign2
Benign1

Top pathogenic / likely-pathogenic (0)

SpliceAI

566 predictions. Top by Δscore:

VariantEffectΔscore
19:56391742:A:ACdonor_gain1.0000
19:56391743:C:CCdonor_gain1.0000
19:56391833:C:CCacceptor_gain1.0000
19:56385185:C:CCacceptor_gain0.9900
19:56389757:T:Adonor_gain0.9900
19:56389997:TCACC:Tdonor_loss0.9900
19:56389998:CACCT:Cdonor_loss0.9900
19:56389999:ACCT:Adonor_loss0.9900
19:56390000:C:Adonor_loss0.9900
19:56390499:CCC:Cacceptor_gain0.9900
19:56390500:CCC:Cacceptor_gain0.9900
19:56391743:CA:Cdonor_gain0.9900
19:56391784:T:TAdonor_gain0.9900
19:56391828:TAGAG:Tacceptor_gain0.9900
19:56391830:GAG:Gacceptor_gain0.9900
19:56391830:GAGC:Gacceptor_loss0.9900
19:56391832:GC:Gacceptor_loss0.9900
19:56391833:C:CAacceptor_loss0.9900
19:56382920:T:Cacceptor_gain0.9800
19:56382924:A:Cacceptor_gain0.9800
19:56385180:CAATA:Cacceptor_gain0.9800
19:56389784:A:ACdonor_gain0.9800
19:56389995:ACTC:Adonor_loss0.9800
19:56390094:GACCT:Gacceptor_loss0.9800
19:56390097:C:CAacceptor_loss0.9800
19:56390368:ACCTT:Adonor_loss0.9800
19:56390369:CCTTA:Cdonor_loss0.9800
19:56390370:CTTA:Cdonor_loss0.9800
19:56390371:TTA:Tdonor_loss0.9800
19:56390372:TA:Tdonor_loss0.9800

AlphaMissense

3458 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
19:56384541:G:CF292L0.997
19:56384541:G:TF292L0.997
19:56384543:A:GF292L0.997
19:56384625:A:CF264L0.997
19:56384625:A:TF264L0.997
19:56384627:A:GF264L0.997
19:56384205:G:CF404L0.995
19:56384205:G:TF404L0.995
19:56384207:A:GF404L0.995
19:56384289:A:CF376L0.995
19:56384289:A:TF376L0.995
19:56384291:A:GF376L0.995
19:56384709:G:CF236L0.995
19:56384709:G:TF236L0.995
19:56384711:A:GF236L0.995
19:56384121:A:CF432L0.994
19:56384121:A:TF432L0.994
19:56384123:A:GF432L0.994
19:56384373:A:CF348L0.994
19:56384373:A:TF348L0.994
19:56384375:A:GF348L0.994
19:56384536:C:GR294P0.994
19:56384457:A:CF320L0.993
19:56384457:A:TF320L0.993
19:56384459:A:GF320L0.993
19:56384593:C:GR275P0.993
19:56384272:A:GL382P0.992
19:56384524:A:GL298P0.991
19:56384188:A:GL410P0.989
19:56384260:T:GQ386P0.987

dbSNP variants (sampled 300 via entrez): RS1000186745 (19:56384447 A>G), RS1000225683 (19:56393738 C>A,G,T), RS1000273150 (19:56386851 A>G), RS1000411706 (19:56391685 A>T), RS1001053163 (19:56388958 A>G), RS1001368561 (19:56385171 T>A,C), RS1002334362 (19:56395154 A>G), RS1002378318 (19:56383578 T>C), RS1002686893 (19:56394864 T>G), RS1003058808 (19:56387034 T>C), RS1003288289 (19:56390210 G>A), RS1003426010 (19:56384343 CTGA>C), RS1004218120 (19:56383460 C>T), RS1004236074 (19:56387465 C>T), RS1004358072 (19:56389377 G>A)

Disease associations

OMIM: gene MIM:615600 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

1 associations (top):

StudyTraitp-value
GCST009269_20Dental caries (decayed and filled deciduous teeth)5.000000e-06

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

20 total (human), top 20 by PubMed support.

ChemicalActions (top 5)PubMed papers
urushioldecreases expression1
triphenyl phosphateaffects expression1
hydroxyhydroquinoneincreases expression1
arsenitedecreases expression, increases methylation1
ferrous chloridedecreases expression1
di-n-butylphosphoric acidaffects expression1
CGP 52608affects binding, increases reaction1
abrineincreases expression1
bisphenol Sdecreases methylation, affects cotreatment1
jinfukangaffects cotreatment, decreases expression1
Irinotecanaffects cotreatment, increases response to substance1
Fulvestrantaffects cotreatment, decreases methylation1
Acetaminophenincreases expression1
Air Pollutantsdecreases expression, increases abundance1
Benzo(a)pyreneaffects methylation1
Cisplatinaffects cotreatment, decreases expression1
Leucovorinaffects cotreatment, increases response to substance1
Fluorouracilincreases response to substance, affects cotreatment1
Valproic Aciddecreases expression1
Particulate Matterdecreases expression, increases abundance1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.